- Home
- AEMD vs OGEN Comparison
AEMD vs OGEN Comparison
Compare AEMD & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEMD
- OGEN
- Stock Information
- Founded
- AEMD 1984
- OGEN 1996
- Country
- AEMD United States
- OGEN United States
- Employees
- AEMD N/A
- OGEN N/A
- Industry
- AEMD Medical/Dental Instruments
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- AEMD Health Care
- OGEN Health Care
- Exchange
- AEMD Nasdaq
- OGEN Nasdaq
- Market Cap
- AEMD 5.0M
- OGEN 5.5M
- IPO Year
- AEMD N/A
- OGEN N/A
- Fundamental
- Price
- AEMD $0.71
- OGEN $0.28
- Analyst Decision
- AEMD Strong Buy
- OGEN
- Analyst Count
- AEMD 1
- OGEN 0
- Target Price
- AEMD $7.00
- OGEN N/A
- AVG Volume (30 Days)
- AEMD 1.3M
- OGEN 507.3K
- Earning Date
- AEMD 02-12-2025
- OGEN 03-28-2025
- Dividend Yield
- AEMD N/A
- OGEN N/A
- EPS Growth
- AEMD N/A
- OGEN N/A
- EPS
- AEMD N/A
- OGEN N/A
- Revenue
- AEMD N/A
- OGEN N/A
- Revenue This Year
- AEMD N/A
- OGEN N/A
- Revenue Next Year
- AEMD N/A
- OGEN N/A
- P/E Ratio
- AEMD N/A
- OGEN N/A
- Revenue Growth
- AEMD N/A
- OGEN N/A
- 52 Week Low
- AEMD $0.24
- OGEN $0.25
- 52 Week High
- AEMD $1.85
- OGEN $4.00
- Technical
- Relative Strength Index (RSI)
- AEMD 51.85
- OGEN 41.56
- Support Level
- AEMD $0.62
- OGEN $0.34
- Resistance Level
- AEMD $0.78
- OGEN $0.32
- Average True Range (ATR)
- AEMD 0.06
- OGEN 0.03
- MACD
- AEMD -0.01
- OGEN 0.00
- Stochastic Oscillator
- AEMD 34.18
- OGEN 41.80
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.